Rubius Therapeutics added to Nasdaq biotechnology index

SMITHFIELD – Biotechnology firm Rubius Therapeutics Inc. was added to the Nasdaq biotechnology index on Dec. 24. The company, based in Cambridge, Mass., but building a facility in Smithfield, announced the development in a news release. Rubius manufactures allogeneic cellular therapies called Red Cell Therapeutics, which have the potential to treat several different kinds of…

Want More?

Subscribe or register with Providence Business News to keep reading.

for 2 more stories

Subscribe now for $1 for 4 weeks
Already a Subscriber? Login now

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -